Literature DB >> 14520238

Bile acids increase response and expression of human myometrial oxytocin receptor.

Alfredo M Germain1, Sumie Kato, Jorge A Carvajal, Guillermo J Valenzuela, Gloria L Valdes, Juan C Glasinovic.   

Abstract

OBJECTIVE: We tested the hypothesis that during intrahepatic cholestasis of pregnancy bile acids activate the myometrial oxytocin receptor pathway. STUDY
DESIGN: Myometrial sensitivity to oxytocin and oxytocin-receptor messenger RNA and protein level was investigated. The ability of cholic acid to mediate such changes was evaluated.
RESULTS: Cholestasis patients required lesser oxytocin to elicit four uterine contractions in 10 minutes (1.3+/-0.6 vs 3.6+/-0.8 U, P<.05, n=7) and had lower in vitro ED(50) (1.6 x 10(-10) mol/L vs 1.0 x 10(-8) mol/L, P<.05, n=7) than controls. The 24-hour incubation of control myometrial strips (n=7) with cholic acid (20 micromol/L) increased oxytocin sensitivity. Incubation of cultured myometrial cells (n=5) with cholic acid increased oxytocin-receptor expression (messenger RNA and protein).
CONCLUSION: We demonstrate that during intrahepatic cholestasis of pregnancy, an activation of the oxytocin receptor pathway occurs. This event seems to be the result of a cholic acid-mediated increase in oxytocin-receptor expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520238     DOI: 10.1067/s0002-9378(03)00545-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  24 in total

Review 1.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 2.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

3.  Good pregnancy outcome despite intrahepatic cholestasis.

Authors:  Kaisa Turunen; Markku Sumanen; Riitta-Liisa Haukilahti; Pertti Kirkinen; Kari Mattila
Journal:  Scand J Prim Health Care       Date:  2010-06       Impact factor: 2.581

4.  Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy.

Authors:  Yuling Liu; Fuyuan Qiao; Haiyi Liu; Dayan Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Predictive Value of Serum Cholic Acid and Lithocholic Acid for the Diagnosis in an Intrahepatic Cholestasis of Pregnancy Population with High Levels of Total Bile Acids and the Correlation with Placental Hypoxia-Inducible Factor-1α.

Authors:  Chu-Yun Cheng; Guan-Yin Zeng; Tong Wang; Yan-Hua Su; Feng-Dan Xu; Hong Luo; Hui-Ting Zhong; Xiu-Lan Chen
Journal:  Int J Womens Health       Date:  2022-05-09

6.  Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy.

Authors:  Jurate Kondrackiene; Ulrich Beuers; Rimantas Zalinkevicius; Horst-Dietmar Tauschel; Vladas Gintautas; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

7.  Cholestasis of Pregnancy : A Prospective Study.

Authors:  G Singh; K Sidhu
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  Maternal cholestasis during pregnancy programs metabolic disease in offspring.

Authors:  Georgia Papacleovoulou; Shadi Abu-Hayyeh; Evanthia Nikolopoulou; Oscar Briz; Bryn M Owen; Vanya Nikolova; Caroline Ovadia; Xiao Huang; Marja Vaarasmaki; Marc Baumann; Eugene Jansen; Christiane Albrecht; Marjo-Riitta Jarvelin; Jose J G Marin; A S Knisely; Catherine Williamson
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

Review 9.  Liver disease in pregnancy.

Authors:  Noel M Lee; Carla W Brady
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

10.  High doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancy.

Authors:  Francesco Azzaroli; Maria Elena Raspanti; Patrizia Simoni; Marco Montagnani; Andrea Lisotti; Paolo Cecinato; Rosario Arena; Giuliana Simonazzi; Antonio Farina; Nicola Rizzo; Giuseppe Mazzella
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.